Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Peptide blend Two or more peptides lyophilised together in a single vial at a ratio fixed by the manufacturer
Mounjaro (Tirzepatide) Dual action: targets both GLP-1 and GIP receptors Strong appetite suppression & improved blood sugar control Clinical trials show average body weight loss up to 22.5% over 72 weeks Wegovy (Semaglutide) Targets GLP-1 receptors only Licensed in the UK for obesity and cardiovascular protection STEP trials show 1521% body weight loss A new 7.2mg dose is expected in late 2025, with results potentially matching Mounjaro Both treatments are once-weekly injections, prescribed alongside healthy diet and lifestyle changes
Trachootham et al., 2008
Autoimmune-associated inflammation For individuals who experience flares or persistent inflammation despite standard therapies
S.Long-SmithC.MorklS.BerdingK.RitzN
They are also low in sugar and contain 24 vitamins and minerals to support your overall nutrient intake when taking GLP-1 medication
